Elsevier scoops up scientific software outfit Ariadne

Amsterdam-based information products giant Elsevier has gobbled up Ariadne Genomics, a company that provides software allowing researchers to study molecular pathways and disease progression. With scientists facing a deluge of data from a number of publications, Rockville, MD-based Ariadne's software uses semantics technologies to tap multiple content sources for material on molecular pathways and disease progression, according to Elsevier. Ariadne, with its main product Pathway Studio, is expected to become part of the buyer's Corporate Markets unit, but financial terms of the deal, which was announced Dec. 8, weren't disclosed. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.